JP2016503067A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016503067A5 JP2016503067A5 JP2015549834A JP2015549834A JP2016503067A5 JP 2016503067 A5 JP2016503067 A5 JP 2016503067A5 JP 2015549834 A JP2015549834 A JP 2015549834A JP 2015549834 A JP2015549834 A JP 2015549834A JP 2016503067 A5 JP2016503067 A5 JP 2016503067A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- cdr
- acid sequence
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261745239P | 2012-12-21 | 2012-12-21 | |
| US61/745,239 | 2012-12-21 | ||
| PCT/US2013/077264 WO2014100740A1 (en) | 2012-12-21 | 2013-12-20 | Anti-ntb-a antibodies and related compositions and methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018203019A Division JP6817674B2 (ja) | 2012-12-21 | 2018-10-29 | 抗ｎｔｂ−ａ抗体ならびに関連する組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016503067A JP2016503067A (ja) | 2016-02-01 |
| JP2016503067A5 true JP2016503067A5 (https=) | 2017-01-12 |
| JP6449777B2 JP6449777B2 (ja) | 2019-01-09 |
Family
ID=50979291
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015549834A Expired - Fee Related JP6449777B2 (ja) | 2012-12-21 | 2013-12-20 | 抗ｎｔｂ−ａ抗体ならびに関連する組成物および方法 |
| JP2018203019A Expired - Fee Related JP6817674B2 (ja) | 2012-12-21 | 2018-10-29 | 抗ｎｔｂ−ａ抗体ならびに関連する組成物および方法 |
| JP2019238780A Withdrawn JP2020055870A (ja) | 2012-12-21 | 2019-12-27 | 抗ｎｔｂ−ａ抗体ならびに関連する組成物および方法 |
| JP2022038055A Withdrawn JP2022066565A (ja) | 2012-12-21 | 2022-03-11 | 抗ｎｔｂ－ａ抗体ならびに関連する組成物および方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018203019A Expired - Fee Related JP6817674B2 (ja) | 2012-12-21 | 2018-10-29 | 抗ｎｔｂ−ａ抗体ならびに関連する組成物および方法 |
| JP2019238780A Withdrawn JP2020055870A (ja) | 2012-12-21 | 2019-12-27 | 抗ｎｔｂ−ａ抗体ならびに関連する組成物および方法 |
| JP2022038055A Withdrawn JP2022066565A (ja) | 2012-12-21 | 2022-03-11 | 抗ｎｔｂ－ａ抗体ならびに関連する組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US9708404B2 (https=) |
| EP (1) | EP2934585B1 (https=) |
| JP (4) | JP6449777B2 (https=) |
| CN (2) | CN105188749B (https=) |
| AU (1) | AU2013364043B2 (https=) |
| CA (1) | CA2893977C (https=) |
| EA (1) | EA031025B1 (https=) |
| HK (1) | HK1216850A1 (https=) |
| IL (2) | IL239211B (https=) |
| WO (1) | WO2014100740A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2693310C (en) * | 2007-08-02 | 2018-11-27 | Arresto Biosciences, Inc. | Lox and loxl2 inhibitors, antibodies and uses thereof |
| AU2013364043B2 (en) * | 2012-12-21 | 2018-01-04 | Seagen Inc. | Anti-NTB-A antibodies and related compositions and methods |
| US9603927B2 (en) | 2014-02-28 | 2017-03-28 | Janssen Biotech, Inc. | Combination therapies with anti-CD38 antibodies |
| US9732154B2 (en) | 2014-02-28 | 2017-08-15 | Janssen Biotech, Inc. | Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia |
| US10428159B2 (en) * | 2014-09-09 | 2019-10-01 | Board Of Regents, The University Of Texas System | Blocking monoclonal antibodies to AGR2 and its receptor C4.4A |
| CN106470697B (zh) * | 2014-09-16 | 2019-10-25 | 兴盟生物医药(苏州)有限公司 | 抗egfr抗体以及其用途 |
| MX388698B (es) * | 2014-09-30 | 2025-03-20 | Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts | Moleculas de enlace, especialmente anticuerpos, enlazadas a l1cam(cd171). |
| EP3212668B1 (en) | 2014-10-31 | 2020-10-14 | AbbVie Biotherapeutics Inc. | Anti-cs1 antibodies and antibody drug conjugates |
| AU2015358615B2 (en) | 2014-12-04 | 2021-08-05 | Janssen Biotech, Inc. | Anti-CD38 antibodies for treatment of acute myeloid leukemia |
| MX389805B (es) | 2015-05-20 | 2025-03-11 | Janssen Biotech Inc | Anticuerpos anti-cd38 para el tratamiento de amiloidosis de cadena ligera y otras enfermedades malignas hematológicas positivas para cd38. |
| US20170044265A1 (en) * | 2015-06-24 | 2017-02-16 | Janssen Biotech, Inc. | Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38 |
| PT3316909T (pt) * | 2015-06-30 | 2023-11-22 | Seattle Genetics Inc | Anticorpos anti-ntb-a e composições e métodos relacionados |
| DK3827845T3 (da) | 2015-11-03 | 2022-05-23 | Janssen Biotech Inc | Subkutane formuleringer af anti-cd38-antistoffer og anvendelser deraf |
| JP2019527678A (ja) | 2016-06-28 | 2019-10-03 | ユーエムセー・ユトレヒト・ホールディング・ベー・フェー | ＣＤ３８に特異的に結合する抗体によるＩｇＥ媒介疾患の治療 |
| JP2021502961A (ja) | 2017-10-31 | 2021-02-04 | ヤンセン バイオテツク，インコーポレーテツド | 高リスク多発性骨髄腫の治療方法 |
| CA3091181A1 (en) * | 2018-02-13 | 2019-08-22 | Precision Biologics, Inc. | Methods and compositions for targeting treg cells |
| CN114008077B (zh) | 2019-07-03 | 2024-10-29 | 牛津生物疗法有限公司 | 抗体和使用方法 |
| WO2021066869A1 (en) * | 2019-10-04 | 2021-04-08 | TAE Life Sciences | Antibody compositions comprising fc mutations and site-specific conjugation properties |
| US20230092356A1 (en) | 2019-12-06 | 2023-03-23 | Thoas Fioretos | Novel agents and uses thereof |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5515508A (en) | 1993-12-17 | 1996-05-07 | Taligent, Inc. | Client server system and method of operation including a dynamically configurable protocol stack |
| WO1996036361A1 (en) * | 1995-05-18 | 1996-11-21 | The Regents Of The University Of Michigan | Dna binding antibodies |
| MA24512A1 (fr) | 1996-01-17 | 1998-12-31 | Univ Vermont And State Agrienl | Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose |
| WO2001053466A1 (en) | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Methods and materials relating to semaphorin-like polypeptides and polynucleotides |
| EP1252333A4 (en) | 2000-01-25 | 2005-01-05 | Nuvelo Inc | METHODS AND SUBSTANCES RELATING TO CD84-TYPE POLYPEPTIDES AND POLYNUCLEOTIDES |
| WO2001079454A1 (en) | 2000-04-13 | 2001-10-25 | Smithkline Beecham Corporation | Novel compounds |
| AU2001274888A1 (en) | 2000-05-19 | 2001-12-03 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
| US6464770B1 (en) | 2000-08-08 | 2002-10-15 | Advanced Minerals Corporation | Perlite products with controlled particle size distribution |
| CA2632702A1 (en) | 2000-09-01 | 2002-03-28 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US7795412B2 (en) | 2000-09-15 | 2010-09-14 | Genentech, Inc. | Nucleic acids encoding PRO6308 polypeptides and related vectors and host cells |
| US20030180888A1 (en) | 2000-11-03 | 2003-09-25 | Millennium Pharmaceuticals, Inc. | CD2000 and CD2001 molecules, and uses thereof |
| EP1223218A1 (en) | 2000-11-03 | 2002-07-17 | Millennium Pharmaceuticals, Inc. | CD2000 and CD2001 molecules and uses thereof |
| US7892730B2 (en) | 2000-12-22 | 2011-02-22 | Sagres Discovery, Inc. | Compositions and methods for cancer |
| JP2004533222A (ja) | 2001-03-12 | 2004-11-04 | インサイト・ゲノミックス・インコーポレイテッド | 免疫グロブリンスーパーファミリータンパク質 |
| CA2454185A1 (en) | 2001-07-19 | 2003-01-30 | Innate Pharma | Ntb-a, a surface molecule involved in natural killer cells activity |
| MXPA04001986A (es) | 2001-08-29 | 2004-06-07 | Genentech Inc | Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad. |
| US20060194265A1 (en) | 2001-10-23 | 2006-08-31 | Morris David W | Novel therapeutic targets in cancer |
| CA2476555A1 (en) | 2002-02-14 | 2003-08-21 | Nuvelo, Inc. | Methods of therapy and diagnosis |
| EP2332956A1 (en) | 2002-07-08 | 2011-06-15 | Genentech, Inc. | Antibody binding to PRO71238 |
| SI1545613T1 (sl) | 2002-07-31 | 2011-11-30 | Seattle Genetics Inc | Avristatinski konjugati in njihova uporaba za zdravljenje raka avtoimunske bolezni ali infekcijskebolezni |
| WO2004016733A2 (en) | 2002-08-16 | 2004-02-26 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
| AU2003303305A1 (en) | 2002-10-02 | 2004-09-30 | Nuvelo,Inc. | Novel nucleic acids and polypeptides |
| WO2005019258A2 (en) | 2003-08-11 | 2005-03-03 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US7498298B2 (en) | 2003-11-06 | 2009-03-03 | Seattle Genetics, Inc. | Monomethylvaline compounds capable of conjugation to ligands |
| WO2005108415A2 (en) | 2004-04-30 | 2005-11-17 | Biogen Idec Ma Inc. | Membrane associated molecules |
| BRPI0513959A (pt) | 2004-07-30 | 2008-05-20 | Rinat Neuroscience Corp | anticorpos dirigidos contra o peptìdeo beta-amilóide, suas composições farmacêuticas, kit e métodos de fabricação dos mesmos |
| JP5171621B2 (ja) | 2005-07-07 | 2013-03-27 | シアトル ジェネティックス， インコーポレイテッド | フェニルアラニン側鎖修飾をｃ末端に有するモノメチルバリン化合物 |
| US8871720B2 (en) | 2005-07-07 | 2014-10-28 | Seattle Genetics, Inc. | Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus |
| BRPI0617546A2 (pt) * | 2005-09-26 | 2011-07-26 | Medarex Inc | conjugado de fÁrmaco-anticorpo, formulaÇço farmacÊutica, mÉtodo para matar uma cÉlula de tumor, mÉtodo para retardar ou interromper o crescimento de um tumor em um sujeito mamÍfero e composto |
| US7847067B2 (en) * | 2006-08-28 | 2010-12-07 | ARCA Biopharma | Antibodies to NTB-A |
| WO2009043944A1 (es) * | 2007-10-03 | 2009-04-09 | Germans Boada, S.A. | Cortadora manual de cerámica |
| AR068723A1 (es) * | 2007-10-05 | 2009-12-02 | Glaxo Group Ltd | Proteina que se une a antigenos que se une a il-23 humana y sus usos |
| RU2476441C2 (ru) | 2007-10-19 | 2013-02-27 | Сиэтл Дженетикс, Инк. | Cd19-связывающие средства и их применение |
| MX2011000970A (es) | 2008-08-29 | 2011-03-15 | Symphogen As | Anticuerpos anti-cd5. |
| CN102333859B (zh) * | 2008-09-16 | 2015-04-22 | 三井化学株式会社 | 由来自植物的原料生产乳酸的方法及生产乳酸的细菌 |
| CA2757237A1 (en) | 2009-04-01 | 2010-10-14 | Jane Elizabeth Clarkson | Anti-il-23 immunoglobulins |
| PE20120622A1 (es) | 2009-06-17 | 2012-05-26 | Abbott Biotherapeutics Corp | Anticuerpos anti-vegf y sus usos |
| US8221753B2 (en) | 2009-09-30 | 2012-07-17 | Tracon Pharmaceuticals, Inc. | Endoglin antibodies |
| US8303093B2 (en) * | 2009-12-15 | 2012-11-06 | Xerox Corporation | Print head having a polymer layer to facilitate assembly of the print head |
| EP2526115B1 (en) | 2010-01-18 | 2018-08-01 | Novo Nordisk Health Care AG | Purification of blood coagulation factors |
| UA108227C2 (xx) * | 2010-03-03 | 2015-04-10 | Антигензв'язуючий білок | |
| KR101820987B1 (ko) | 2010-04-15 | 2018-01-22 | 프로제닉스 파머슈티컬스, 인코포레이티드 | 클로스트리듐 디피실리 관련 감염 및 질병의 치료를 위한 항체 |
| US9243057B2 (en) * | 2010-08-31 | 2016-01-26 | The Regents Of The University Of California | Antibodies for botulinum neurotoxins |
| PH12016502073B1 (en) * | 2010-11-17 | 2024-04-05 | Chugai Pharmaceutical Co Ltd | Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii |
| CN106963947A (zh) | 2010-11-22 | 2017-07-21 | 伊纳特医药股份有限公司 | Nk细胞调节治疗和用于治疗血液恶性疾病的方法 |
| AP2014007415A0 (en) | 2011-07-11 | 2014-02-28 | Glenmark Pharmaceuticals Sa | Antibodies that bind to OX40 and their uses |
| US8790651B2 (en) * | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| AU2013364043B2 (en) * | 2012-12-21 | 2018-01-04 | Seagen Inc. | Anti-NTB-A antibodies and related compositions and methods |
| EP2824112B1 (en) * | 2013-07-10 | 2016-12-21 | Miltenyi Biotec GmbH | Method for inducing proliferation of Natural Killer cells by mobile nanomatrices |
| PT3316909T (pt) * | 2015-06-30 | 2023-11-22 | Seattle Genetics Inc | Anticorpos anti-ntb-a e composições e métodos relacionados |
-
2013
- 2013-12-20 AU AU2013364043A patent/AU2013364043B2/en not_active Ceased
- 2013-12-20 EA EA201591191A patent/EA031025B1/ru unknown
- 2013-12-20 HK HK16104822.8A patent/HK1216850A1/zh unknown
- 2013-12-20 CN CN201380073489.9A patent/CN105188749B/zh not_active Expired - Fee Related
- 2013-12-20 JP JP2015549834A patent/JP6449777B2/ja not_active Expired - Fee Related
- 2013-12-20 WO PCT/US2013/077264 patent/WO2014100740A1/en not_active Ceased
- 2013-12-20 US US14/758,430 patent/US9708404B2/en active Active
- 2013-12-20 EP EP13863944.8A patent/EP2934585B1/en active Active
- 2013-12-20 CN CN201711276208.6A patent/CN107880126B/zh not_active Expired - Fee Related
- 2013-12-20 CA CA2893977A patent/CA2893977C/en active Active
-
2015
- 2015-06-04 IL IL239211A patent/IL239211B/en active IP Right Grant
-
2017
- 2017-06-14 US US15/622,411 patent/US10435468B2/en active Active
-
2018
- 2018-10-29 JP JP2018203019A patent/JP6817674B2/ja not_active Expired - Fee Related
-
2019
- 2019-08-28 US US16/553,525 patent/US20190375841A1/en not_active Abandoned
- 2019-12-10 IL IL271305A patent/IL271305B/en active IP Right Grant
- 2019-12-27 JP JP2019238780A patent/JP2020055870A/ja not_active Withdrawn
-
2022
- 2022-03-11 JP JP2022038055A patent/JP2022066565A/ja not_active Withdrawn
- 2022-08-15 US US17/819,819 patent/US20230105802A1/en not_active Abandoned